WuXi XDC Cayman (STU:L74) 3-Year Share Buyback Ratio : -0.60% (As of Dec. 2024)

View and export this data going back to 2023. Start your Free Trial

What is WuXi XDC Cayman 3-Year Share Buyback Ratio?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

3-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past three years. It is calculated as the annualized percentage change in shares outstanding from three years ago to the current year. A positive ratio may indicate share buybacks over the period, while a zero or negative ratio may reflect no repurchases or potential share issuance. WuXi XDC Cayman's current 3-Year Share Buyback Ratio was -0.60%.

The historical rank and industry rank for WuXi XDC Cayman's 3-Year Share Buyback Ratio or its related term are showing as below:

STU:L74' s 3-Year Share Buyback Ratio Range Over the Past 10 Years
Min: -0.6 Med: -0.55 Max: -0.5
Current: -0.6

During the past 5 years, WuXi XDC Cayman's highest 3-Year Share Buyback Ratio was -0.50%. The lowest was -0.60%. And the median was -0.55%.

STU:L74's 3-Year Share Buyback Ratio is ranked better than
61.45% of 179 companies
in the Medical Diagnostics & Research industry
Industry Median: -2.6 vs STU:L74: -0.60

Competitive Comparison of WuXi XDC Cayman's 3-Year Share Buyback Ratio

For the Diagnostics & Research subindustry, WuXi XDC Cayman's 3-Year Share Buyback Ratio, along with its competitors' market caps and 3-Year Share Buyback Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

WuXi XDC Cayman's 3-Year Share Buyback Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, WuXi XDC Cayman's 3-Year Share Buyback Ratio distribution charts can be found below:

* The bar in red indicates where WuXi XDC Cayman's 3-Year Share Buyback Ratio falls into.

Save Embed

;

Save Embed

;

WuXi XDC Cayman 3-Year Share Buyback Ratio Calculation

This is the annualized percentage change in shares outstanding from three years ago to the current year. The annualized percentage change is calculated with expontential compound based on the latest four years of annual data on Shares Outstanding (EOP).

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

WuXi XDC Cayman (STU:L74) 3-Year Share Buyback Ratio Explanation

A negative number means the company might be issuing new shares. A positive number indicates that the company is buying back shares.

Be Aware

Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.

WuXi XDC Cayman 3-Year Share Buyback Ratio Related Terms

Thank you for viewing the detailed overview of WuXi XDC Cayman's 3-Year Share Buyback Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

WuXi XDC Cayman Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » WuXi XDC Cayman Inc (STU:L74) » Definitions » 3-Year Share Buyback Ratio

Comparable Companies

Traded in Other Exchanges

02268:Hong Kong L74:Germany

Address

No. 11 Xinhui Ring Road, Xinwu, Jiangsu Province, Wuxi, CHN

Website

https://www.wuxixdc.com

WuXi XDC Cayman Inc is a CRDMO focused on the ADC and broader bioconjugate market and is the only one dedicated to providing integrated and end-to-end services. Leveraging expertise in both biologics and small molecules, it offers interdisciplinary and comprehensive services, covering bioconjugate discovery, research, development, and manufacturing. The company provides these services from proximately located laboratories and manufacturing facilities, resulting in the reduction of development timeline and costs. As a fully integrated one-stop bioconjugate discovery, development, and manufacturing platform, its mission is to continuously enhance its platform and propel and transform the development of the bioconjugate industry.

WuXi XDC Cayman Headlines

No Headlines